Events in 2022

BIOHK2021 Banner 3 s

Hong Kong, being the gateway to China, provides a rich source of opportunities for overseas investors looking to capitalize on the growth of the Greater Bay Area (GBA). Meanwhile, for companies from China, Hong Kong is a bridge to connect with the West. Moreover, the new listing rules adopted by the Hong Kong Stock Exchange (HKEX) which allow pre-revenue biotech companies to be listed on the HKEX is a bold imperative step for the growth of the biotech sector in Hong Kong. Thus, we could not think of a better way to kick-start the Asian biotech revolution than by organizing BIOHK2022 convention in Hong Kong, the potential biotech epicentre of Asia. This is a golden opportunity to personally view the major GBA cities involved in the future of biotechnology by becoming a part of this historical event.

香港生物科技協會(HKBIO)聯同粵港澳大灣區生物科技聯盟(GBABA)及香港生物醫藥創新協會(HKBMIA)舉辦生物科技業界與創新科技局局長會談,反映業內情況及冀望與局長深切對話。

日期:2022年9月8日
時間:下午2:30至4:00
地點:香港金鐘統一中心8樓815室
人數:約40多位實體及 50多位Zoom
形式:線上/線下 同步進行
語言:廣東話/普通話

[Modern Chinese Medicine] The Scientific Rationale of Heat Toxin-induced Blood Stasis and Cooling Blood by Clearing Heat: Discussion on the Ameliorative Effect and Mechanism of TCM in Treating COVID-19

 

Host: Prof. YU Cheung-Hoi, Ph.D., JP

Speaker: Prof. HAN Jing Yan

 

 

 

Free Joomla! template by Age Themes